Management of Threatened Preterm Labor
For threatened preterm labor at ≥24 weeks with intact membranes, perform transvaginal cervical length measurement to guide management—women with cervical length >30mm can be safely managed expectantly without tocolysis or corticosteroids, while those with cervical length ≤30mm should receive corticosteroids and short-term tocolysis (48 hours maximum) to allow steroid completion. 1
Diagnostic Approach
The diagnosis requires three components working together:
- Clinical assessment: Regular uterine contractions (≥4 per 20 minutes or ≥8 per hour)
- Cervical changes: Documented by serial examinations
- Transvaginal ultrasound cervical length: This is the first-line diagnostic test 1, 2
Key diagnostic tool: Transvaginal cervical length measurement has excellent negative predictive value—women with cervical length >30mm have <1% risk of delivery within 7 days 3. If cervical length is 15-30mm and no fluid is visible on speculum exam, consider IGFBP-1 or PAMG-1 testing to further stratify risk 1.
Risk Stratification Algorithm
High-risk (requires intervention):
- Cervical length <15mm
- Cervical length 15-30mm with >20% shortening on serial measurements 4
- Positive biomarkers (fetal fibronectin, PAMG-1) with cervical length ≤30mm
Low-risk (expectant management):
- Cervical length >30mm regardless of contractions 3
- Cervical length 15-30mm without progressive shortening 4
Treatment Protocol
For High-Risk Patients (24-33+6 weeks):
Corticosteroids (GRADE 1A):
- Administer between 24+0 and 33+6 weeks 1
- Can be considered up to 35+6 weeks 1
- Single course only—goal is fetal lung maturation
Tocolysis (short-term only):
- Duration: 48 hours maximum—only to allow corticosteroid completion 2
- Agent selection: Nifedipine (calcium channel blocker) is preferred first-line
- Critical caveat: Prolonged maintenance tocolysis (especially ritodrine) is NOT supported by evidence and increases maternal side effects without improving outcomes 5
Magnesium sulfate for neuroprotection:
- Administer if delivery expected within 24 hours
- Between 24+0 and 29+6 weeks (GRADE 1A) 1
Antibiotics:
- NOT routinely recommended for threatened preterm labor with intact membranes 6
- Only indicated if documented infection (positive urine culture, Group B Strep) 6
For Low-Risk Patients:
Expectant management is safe 4, 3:
- No tocolysis required
- No corticosteroids if cervical length stable >30mm
- Serial cervical length monitoring every 2-4 hours if contractions persist 4
- Outpatient management appropriate for most 3
What NOT to Do (Common Pitfalls)
Avoid these interventions (they increase harm without benefit):
- Prolonged hospitalization: Does not reduce preterm birth risk and increases thromboembolism 6
- Bed rest: No benefit, increases thromboembolism risk (Grade C recommendation against) 6
- Routine antibiotics: Not indicated without documented infection (Grade A) 6
- Maintenance tocolysis beyond 48 hours: No evidence of benefit, significant maternal side effects 5, 2
- Treating all women with contractions: 89% of admissions can be safely avoided using cervical length-based triage 3
Monitoring Strategy
If expectant management chosen:
- Repeat cervical length every 2 hours if contractions <10 minutes apart
- Every 4 hours if contractions >10 minutes apart or irregular 4
- Escalate to treatment if cervical shortening >20% from baseline or length drops below 15mm 4
Home uterine activity monitoring: Not recommended—no proven benefit 6
Special Considerations
At 34-36+6 weeks: The evidence for intervention becomes less clear. Most guidelines recommend expectant management at ≥34 weeks unless delivery is imminent, as neonatal outcomes are generally favorable 2.
With cerclage in place: Discuss risks/benefits of removal versus leaving in situ—either approach is reasonable with shared decision-making 7
Evidence Strength
The 2019 RCOG guideline 1 and 2022 comprehensive review 2 provide the strongest framework. The 2026 RCT 4 demonstrates that cervical length-based expectant management reduces inappropriate treatment by 92% without missing true preterm labor cases. The QUiPP App study 3 validates that risk-stratified approaches safely avoid 89% of unnecessary admissions compared to treat-all strategies.